COST-EFFECTIVENESS OF ASENAPINE VERSUS ATYPICAL ANTIPSYCHOTICS USED IN TURKEY IN THE TREATMENT OF BIPOLAR I DISORDER

被引：0
|
作者：
Pala, M. [1 ]
Ozdemir, S. [1 ]
Ozdemir, O. [2 ]
机构：
[1] Lundbeck, Istanbul, Turkey
[2] Yorum Consultancy Ltd, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A548 / A548
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Krysanov, I
    Tsfasman, F. M.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [22] Cost-effectiveness of treating schizophrenia with atypical antipsychotics
    Lewis, M
    Frangou, S
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 172 - 172
  • [23] Cost-effectiveness of treating schizophrenia with atypical antipsychotics
    Lewis, M
    Frangou, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 338 - 339
  • [24] Cost-effectiveness of atypical antipsychotics in chronic schizophrenia
    Amin, S
    HOSPITAL MEDICINE, 1999, 60 (06): : 410 - 413
  • [25] Meta-analyses of the efficacy of asenapine versus placebo in bipolar I disorder as monotherapy and adjunct therapy compared with other atypical antipsychotics
    Fennema, H.
    Slaap, B.
    Szegedi, A.
    BIPOLAR DISORDERS, 2011, 13 : 44 - 44
  • [26] Cost-effectiveness of olanzapine versus lithium for the prevention of relapse in bipolar I disorder in Australia
    Price, N
    Davey, P
    Mudge, M
    Fitzgerald, B
    Rajan, N
    Montgomery, B
    VALUE IN HEALTH, 2004, 7 (03) : 273 - 274
  • [27] COST-EFFECTIVENESS OF ASENAPINE IN THE TREATMENT OF SCHIZOPHRENIA IN CANADA
    Lachaine, J.
    Beauchemin, C.
    Mathurin, K.
    Gilbert, D.
    Beillat, M.
    Corson, H.
    VALUE IN HEALTH, 2012, 15 (04) : A88 - A88
  • [28] Cost-effectiveness of ethyleicosapentaenoic acid in the treatment of bipolar disorder
    Cheema, Nadir
    Frangou, Sophia
    McCrone, Paul
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (02) : 73 - 81
  • [29] The role of atypical antipsychotics in the treatment of bipolar disorder
    Hirschfeld, RMA
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 3 - 4
  • [30] Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
    Davies, Andrew
    Vardeva, Kawitha
    Loze, Jean-Yves
    L'Italien, Gilbert J.
    Sennfalt, Karin
    van Baardewijk, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3275 - 3285
12345